Alloderm
Appearance
It has been suggested that this article be merged into ECM Biomaterial. (Discuss) Proposed since June 2016. |
Alloderm is an ECM Biomaterial used in medicine.[1] Alloderm is marketed by and a registered trademark of the LifeCell Corporation based in Bridgewater, NJ[2]. Alloderm has been used to reconstruct breasts experimentally after breast cancer surgery.[3] Alloderm has been used as a gingival graft in periodontics; when using Alloderm, there is no need for a palatal donor site [4] Alloderm has been used for abdominal hernia repair.[5] Alloderm has been used in otorhinolaryngology as implants to rebuild resected turbinates in the treatment of Empty nose syndrome.[6]
Legal issues with Alloderm and hernia repair
References
- ^ "LifeCell: AlloDerm® Tissue Matrix defined". www.lifecell.com. Retrieved 2016-06-10.
- ^ "Acelity - ALLODERM SELECT™ Regenerative Tissue Matrix". www.lifecell.com. Retrieved 2016-06-12.
- ^ Salzberg, C. Andrew (2006-07-01). "Nonexpansive immediate breast reconstruction using human acellular tissue matrix graft (AlloDerm)". Annals of Plastic Surgery. 57 (1): 1–5. doi:10.1097/01.sap.0000214873.13102.9f. ISSN 0148-7043. PMID 16799299.
- ^ Hirsch A, Goldstein M, Goultschin J, Boyan BD, Schwartz Z (2005). "A 2-year follow-up of root coverage using sub-pedicle acellular dermal matrix allografts and subepithelial connective tissue autografts". Journal of Periodontology. 76 (8): 1323–8. doi:10.1902/jop.2005.76.8.1323. PMID 16101365.
- ^ Misra, S.; Raj, P. K.; Tarr, S. M.; Treat, R. C. (2008-06-01). "Results of AlloDerm use in abdominal hernia repair". Hernia: The Journal of Hernias and Abdominal Wall Surgery. 12 (3): 247–250. doi:10.1007/s10029-007-0319-z. ISSN 1265-4906. PMID 18209948.
- ^ Leong SC. The clinical efficacy of surgical interventions for empty nose syndrome: A systematic review. Laryngoscope. 2015 Jul;125(7):1557-62. Review. PMID 25647010